Back to Search
Start Over
EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis
- Source :
- Annals of the Rheumatic Diseases, Vol. 71, No 5 (2012) pp. 638-41, Gerlag, D M, Raza, K, van Baarsen, L G M, Brouwer, E, Buckley, C D, Burmester, G R, Gabay, C, Catrina, A I, Cope, A P, Cornelis, F, Dahlqvist, S R, Emery, P, Eyre, S, Finckh, A, Gay, S, Hazes, JM, van der Helm-va Mil, A, Huizinga, T W J, Klareskog, L, Kvien, T K, Lewis, C, Machold, K P, Ronnelid, J, van Schaardenburg, D, Schett, G, Smolen, J S, Thomas, S, Worthington, J & Tak, P P 2012, ' EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis ', Annals of the Rheumatic Diseases, vol. 71, no. 5, pp. 638-641 . https://doi.org/10.1136/annrheumdis-2011-200990, Annals of the Rheumatic Diseases, Annals of the Rheumatic Diseases, 71(5), 638-641, Annals of the Rheumatic Diseases, 71(5), 638-641. BMJ Publishing Group
- Publication Year :
- 2012
-
Abstract
- The Study Group for Risk Factors for Rheumatoid Arthritis was established by the EULAR Standing Committee on Investigative Rheumatology to facilitate research into the preclinical and earliest clinically apparent phases of rheumatoid arthritis (RA). This report describes the recommendation for terminology to be used to define specific subgroups during different phases of disease, and defines the priorities for research in this area. Terminology was discussed by way of a three-stage structured process: A provisional list of descriptors for each of the possible phases preceding the diagnosis of RA were circulated to members of the study group for review and feedback. Anonymised comments from the members on this list were fed back to participants before a 2-day meeting. 18 participants met to discuss these data, agree terminologies and prioritise important research questions. The study group recommended that, in prospective studies, individuals without RA are described as having: genetic risk factors for RA; environmental risk factors for RA; systemic autoimmunity associated with RA; symptoms without clinical arthritis; unclassified arthritis; which may be used in a combinatorial manner. It was recommended that the prefix ‘pre-RA with:’ could be used before any/any combination of the five points above but only to describe retrospectively a phase that an individual had progressed through once it was known that they have developed RA. An approach to dating disease onset was recommended. In addition, important areas for research were proposed, including research of other tissues in which an adaptive immune response may be initiated, and the identification of additional risk factors and biomarkers for the development of RA, its progression and the development of extra-articular features. These recommendations provide guidance on approaches to describe phases before the development of RA that will facilitate communication between researchers and comparisons between studies. A number of research questions have been defined, requiring new cohorts to be established and new techniques to be developed to image and collect material from different sites.
- Subjects :
- medicine.medical_specialty
Biomedical Research
2745 Rheumatology
Immunology
MEDLINE
Placebo-controlled study
Arthritis
610 Medicine & health
Disease
PLACEBO-CONTROLLED TRIAL
General Biochemistry, Genetics and Molecular Biology
CLASSIFICATION
Terminology
Arthritis, Rheumatoid
DOUBLE-BLIND
Rheumatology
Medizinische Fakultät
1300 General Biochemistry, Genetics and Molecular Biology
Internal medicine
Terminology as Topic
medicine
Immunology and Allergy
CRITERIA
Humans
ddc:610
Prospective cohort study
CYCLIC CITRULLINATED PEPTIDE
ddc:616
2403 Immunology
business.industry
ARTHRALGIA
10051 Rheumatology Clinic and Institute of Physical Medicine
Recommendation
medicine.disease
Arthritis, Rheumatoid/diagnosis/physiopathology
Family medicine
Rheumatoid arthritis
BLOOD-DONORS
ANTIBODIES
ONSET
Practice Guidelines as Topic
Physical therapy
2723 Immunology and Allergy
AUTOANTIBODIES
business
Subjects
Details
- Language :
- English
- ISSN :
- 00034967
- Database :
- OpenAIRE
- Journal :
- Annals of the Rheumatic Diseases, Vol. 71, No 5 (2012) pp. 638-41, Gerlag, D M, Raza, K, van Baarsen, L G M, Brouwer, E, Buckley, C D, Burmester, G R, Gabay, C, Catrina, A I, Cope, A P, Cornelis, F, Dahlqvist, S R, Emery, P, Eyre, S, Finckh, A, Gay, S, Hazes, JM, van der Helm-va Mil, A, Huizinga, T W J, Klareskog, L, Kvien, T K, Lewis, C, Machold, K P, Ronnelid, J, van Schaardenburg, D, Schett, G, Smolen, J S, Thomas, S, Worthington, J & Tak, P P 2012, ' EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis ', Annals of the Rheumatic Diseases, vol. 71, no. 5, pp. 638-641 . https://doi.org/10.1136/annrheumdis-2011-200990, Annals of the Rheumatic Diseases, Annals of the Rheumatic Diseases, 71(5), 638-641, Annals of the Rheumatic Diseases, 71(5), 638-641. BMJ Publishing Group
- Accession number :
- edsair.doi.dedup.....0736634e572297565dfe2da209ead809